INTERFERON ALFA-2A IN TREATMENT OF REFRACTORY UVEITIS ASSOCIATED BEHCET'S DISEASE: A SINGLE-CENTRE EXPERIENCE iN CHINA

被引：0
|
作者：
Zheng, W. [1 ]
Shi, J. [1 ]
Zhao, C. [1 ]
Zhang, M. [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Rheumatol, Beijing, Peoples R China
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2016年 / 34卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P113
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [1] Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behcet's Disease
    Park, Ji-Youn
    Chung, Yoo-Ri
    Lee, Kihwang
    Song, Ji Hun
    Lee, Eun-So
    YONSEI MEDICAL JOURNAL, 2015, 56 (04) : 1158 - 1162
  • [2] Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease
    Wechsler, B
    Bodaghi, B
    Huong, DLT
    Fardeau, C
    Amoura, Z
    Cassoux, N
    Piette, JC
    LeHoang, P
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2000, 8 (04) : 293 - 301
  • [3] Tocilizumab in the Treatment of Severe and/or Refractory Behcet's Disease: a Single-Centre Experience in China
    Zheng, Wenjie
    Ding, Yanxia
    Wu, Di
    Zhou, Jiaxin
    Liu, JinJing
    Yan, Dong
    Zhou, Mengyu
    Zhao, Yan
    Zhang, Fengchun
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] Interferon alfa-2a in the treatment of Behcet's disease
    Azizlerli, G
    Sarica, R
    Kose, A
    Ovul, C
    Kavala, M
    Kayabali, M
    Erkan, F
    Kural, Z
    DERMATOLOGY, 1996, 192 (03) : 239 - 241
  • [5] Efficacy and safety of interferon Alfa-2A in intractable Behcet's disease associated uveitis.
    Gendron, G
    Wechsler, B
    Bodaghi, B
    Huong, DLT
    Fardeau, C
    Amoura, Z
    Cassoux, N
    Piette, JC
    Le Hoang, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S182 - S182
  • [6] Efficacy and safety of interferon alfa-2a in intractable Behcet's disease-associated uveitis
    Gendron, G
    Bodaghi, B
    Wechsler, B
    Huong, DLT
    Fardeau, C
    Cassoux, N
    Piette, JC
    Le Hoang, P
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U417 - U417
  • [7] Tocilizumab in the treatment of severe and/or refractory vasculo-Behcet's disease: a single-centre experience in China
    Zheng, W. J.
    Ding, Y. X.
    Li, C. R.
    Liu, J. J.
    Yu, X.
    Shi, J.
    Wang, Y. N.
    Zhao, Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S174 - S174
  • [8] Tocilizumab in the treatment of severe and/or refractory vasculo-Behcet's disease: a single-centre experience in China
    Ding, Yanxia
    Li, Chaoran
    Liu, Jinjing
    Yu, Xin
    Wang, Yining
    Shi, Jing
    Li, Lu
    Zhou, Jiaxin
    Wang, Li
    Chen, Hua
    Zhao, Yan
    Zheng, Wenjie
    RHEUMATOLOGY, 2018, 57 (11) : 2057 - 2059
  • [9] GOLIMUMAB IN THE TREATMENT OF SEVERE AND/OR REFRACTORY VASCULO-BEHCET'S DISEASE: A SINGLE-CENTRE EXPERIENCE IN CHINA
    Sun, L.
    Liu, J.
    Zheng, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1558 - 1559
  • [10] Low-dose Interferon Alfa-2a Therapy in Severe Uveitis Associated with Behcet Disease
    Onal, Sumru
    Kazokoglu, Haluk
    Direskeneli, Haner
    Yavuz, Sule
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (06) : 1109 - 1110
12345